Skip to content

Mater-Bronx Rapid HIV Testing Project.

Mater _Bronx Rapid HIV Testing Project. Prospective Randomised Trial of Recruitment Methods in Implementation of a HIV Screening Programme in the Emergency Department.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01778374
Acronym
M-BRiHT
Enrollment
17000
Registered
2013-01-29
Start date
2012-09-30
Completion date
2020-12-31
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus

Keywords

Emergency Medicine, Screening, Point of care testing, Video assisted counseling

Brief summary

In the M-BRiHT study we aim to implement a programme of opportunistic HIV screening in the Emergency Department, Mater Misericordiae University Hospital. We hypothesize that such a programme will be acceptable in an Irish setting. We also wish to study the factors that influence test completion or acceptance. We will utilise informative interactive video media via a touch-screen tablet device to provide pre-test counselling and then offer rapid minimally invasive testing with a cotton-bud type swab of the buccal mucosa. In doing so we will to determine absolute numbers of those attending the ED who consent to watching the interactive information video about rapid HIV test screening. We will describe the absolute number and proportion of those who watch the interactive video who subsequently proceed to have the rapid HIV test. The primary aim is to determine the cultural, gender and ethnic factors which influence the completion of such rapid HIV testing with the future objective of maximising test completion in this crucial public health area.

Interventions

OTHERNo participant choice of counselor

Participants in this arm of the study are randomized to an interactive video counselor with no choice of counselor. This is delivered via a touchscreen tablet device.

OTHERParticipant choice of counselor

Participants in this arm of the study are randomized to an interactive video counselor with a choice of four different counselors. These gender and ethnically diverse counselors are delivered via a touchscreen tablet device.

Sponsors

University College Dublin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All adults greater than 18 years of age who present to the Emergency Department, Mater Misericordiae University Hospital * Must have capacity to consent to watch an interactive video tablet device about HIV and HIV screening test.

Exclusion criteria

* HIV positive patients (known previous HIV positive patients). * Acute intoxication in which capacity is impaired * Critically unwell patients who require active or intensive resuscitation. * Acute psychiatric disturbance in which capacity is impaired

Design outcomes

Primary

MeasureTime frameDescription
Number of patients agreeing to undergo a HIV screening test in the Emergency Department24 monthsEstablish a programme of HIV screening in the Emergency Department, Mater Misericordiae University Hospital. Acceptability of the programme will be judged in terms of absolute numbers of patients consenting to the test.

Secondary

MeasureTime frame
To determine the proportions of those who test negative who may fall in to the three month seroconversion window and to determine the proportion of those who return for repeat/multiple HIV tests at three months or other time in the future.24 months
Absolute numbers of those attending the ED who consent to watching the interactive information video about rapid HIV test screening.24 months
Absolute number and proportion of HIV positive test results24 months
CD4 count and viral load of newly diagnosed HIV positive patients24 months
Number of those testing positive who have acute seroconversion illness24 months

Countries

Ireland

Contacts

Primary ContactGerard S O'Connor, MB, MCEM
geroconnor@me.com+353861732060
Backup ContactPatrick WG Mallon, MB,FRCPI,PhD
Paddy.Mallon@ucd.ie+35317166311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026